Dong Xiang M.D.
Locations
2904 W Horizon Ridge Pkwy
Suite 200
Henderson, NV 89052
6450 Medical Center St.
Las Vegas, NV 89148
Education
- Doctor of Medicine – Southern Medical University, Guangzhou, China
- M.S., Molecular Biology – University of Alabama, Tuscaloosa, AL
- M.S., Computer Science – State University of New York at Albany, NY
- Residency, Internal Medicine – New Hanover Regional Medical Center, Wilmington, NC
- Fellowship, Hematology & Oncology – University of Louisville, KY
Biography
Dr. Dong Xiang is a board-certified hematologist-oncologist committed to state-of-the-art patient care and translational research. He earned his M.D. from Southern Medical University in 1989, followed by an M.S. in Molecular Biology at the University of Alabama and an M.S. in Computer Science at SUNY Albany. After completing his Internal Medicine residency at New Hanover Regional Medical Center and Hematology-Oncology fellowship at the University of Louisville, he joined Providence St. Vincent Medical Center in 2021, where he directs early-phase clinical trials and leads biomarker discovery efforts. Dr. Xiang has authored numerous publications in microarray analytics, immunotherapy, and molecular oncology, and he brings a compassionate, patient-centered approach to every consultation.
Certifications & Awards
- ECFMG Certificate, 2003
- Board Certified, Internal Medicine, 2008
- Board Certified, Hematology, 2011
- Board Certified, Medical Oncology, 2011
- 1st Place, “Lower Low-Density Lipoprotein Cholesterol Levels Are Associated with Parkinson’s Disease,” ACP Internal Medicine Meeting, 2008
- 1st Place, “Targeting HER-2/neu Antigen to B Cells,” Research!Louisville Retreat, 2009
Professional Memberships
- American Society of Clinical Oncology
- American Society of Hematology
- American College of Physicians
Publications:
- Adjustment of Systematic Microarray Data Biases. Bioinformatics. 20(1):105–14, 2004.
- Molecular Classification of Head and Neck Squamous Cell Carcinomas. Cancer Cell. 5(5):489–500, 2004.
- A Robust Toolkit for Functional Profiling of the Yeast Genome. Mol. Cell. 16(3):487–96, 2004.
- Plasma Thermogram Profiling: A Novel Biomarker for Lung Cancer. ASCO Annual Meeting, Abstract e22074, 2009.
- A Vaccine Approach for Breast-Cancer Immunotherapy Targeting HER-2/neu Antigen. ASCO Breast Cancer Symposium, 2011.
